Literature DB >> 18462913

Neurotrophin-3 reduces apoptosis induced by 6-OHDA in PC12 cells through Akt signaling pathway.

Zhiquan Li1, Yunyu Hu, Qingsheng Zhu, Jinyu Zhu.   

Abstract

Previous work has demonstrated that 6-hydroxydopamine (6-OHDA) induces apoptosis in PC12 cells. The goal of the present study was to investigate the mechanisms underlying the protection by neurotrophin-3 (NT-3) against 6-OHDA-induced apoptosis in PC12 cells. Treatment of PC12 cells with 6-OHDA resulted in activation of caspase-3 and subsequent apoptosis, as detected by TUNEL staining. In addition, Akt phosphorylation was decreased following 6-OHDA treatment. Pretreatment with NT-3 reduced the percentage of apoptotic cells and caspase-3 activity induced by 6-OHDA and suppressed the cleavage of caspase-3 and Poly(ADP-ribose) polymerase (PARP) with a significant decrease in cell viability. Moreover, Akt phosphorylation was enhanced and 6-OHDA-induced chromatin condensation was suppressed by NT-3. Such NT-3-evoked suppression in chromatin condensation was reversed by anti-TrkA antibody receptor blockade. Further study revealed that LY294002, an inhibitor of PI3-kinase (a molecule upstream of Akt), enhanced 6-OHDA-induced apoptosis. These data indicate that NT-3 prevents 6-OHDA-induced apoptosis in PC12 cells via activation of PI3-kinase/Akt pathway.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18462913     DOI: 10.1016/j.ijdevneu.2008.03.009

Source DB:  PubMed          Journal:  Int J Dev Neurosci        ISSN: 0736-5748            Impact factor:   2.457


  6 in total

1.  Transcriptional alterations under continuous or pulsatile dopaminergic treatment in dyskinetic rats.

Authors:  E Grünblatt; W J Schmidt; D K A Scheller; P Riederer; M Gerlach
Journal:  J Neural Transm (Vienna)       Date:  2010-12-25       Impact factor: 3.575

Review 2.  Mitochondrial kinases in Parkinson's disease: converging insights from neurotoxin and genetic models.

Authors:  Ruben K Dagda; Jianhui Zhu; Charleen T Chu
Journal:  Mitochondrion       Date:  2009-06-27       Impact factor: 4.160

3.  Intranasal Administration of GDNF Protects Against Neural Apoptosis in a Rat Model of Parkinson's Disease Through PI3K/Akt/GSK3β Pathway.

Authors:  Peijian Yue; Lin Gao; Xuejing Wang; Xuebing Ding; Junfang Teng
Journal:  Neurochem Res       Date:  2017-02-28       Impact factor: 3.996

4.  Survival, differentiation, and neuroprotective mechanisms of human stem cells complexed with neurotrophin-3-releasing pharmacologically active microcarriers in an ex vivo model of Parkinson's disease.

Authors:  Nicolas Daviaud; Elisa Garbayo; Laurence Sindji; Alberto Martínez-Serrano; Paul C Schiller; Claudia N Montero-Menei
Journal:  Stem Cells Transl Med       Date:  2015-04-29       Impact factor: 6.940

5.  DJ-1 protects the nigrostriatal axis from the neurotoxin MPTP by modulation of the AKT pathway.

Authors:  Hossein Aleyasin; Maxime W C Rousseaux; Paul C Marcogliese; Sarah J Hewitt; Isabella Irrcher; Alvin P Joselin; Mohammad Parsanejad; Raymond H Kim; Patrizia Rizzu; Steve M Callaghan; Ruth S Slack; Tak W Mak; David S Park
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-26       Impact factor: 11.205

6.  Neuroprotective effects of ginsenosides Rh1 and Rg2 on neuronal cells.

Authors:  Xiao-Fan Li; Cathy Nga-Ping Lui; Zhi-Hong Jiang; Yung Kin-Lam Ken
Journal:  Chin Med       Date:  2011-05-19       Impact factor: 5.455

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.